Economic and environmental factors affecting the sustainability of peptide therapeutic manufacturing
Expert views
The outlook for peptide therapeutic drugs is bright. The range of medical indications is expanding and the rate at which peptide therapeutic drugs are being approved is increasing. New formulations and alternative delivery modalities are overcoming many of the inherent weaknesses of peptide-based pharmaceuticals. From many perspectives, peptide therapeutics are benefiting from the success of biologics.
E. R. Lax and T. Shah, ed. Royal Society of Chemistry, London, UK, 2019, 151.
doi:10.1039/9781788016445-00151